ESC 365 - Deep dive and Q&A: unraveling the differences between MRAs for the treatment of heart and kidney disease. Join a conversation discussing key evidence!

Open Access

Deep dive and Q&A: unraveling the differences between MRAs for the treatment of heart and kidney disease. Join a conversation discussing key evidence!

Session: Improving patient outcomes in heart failure: the role of finerenone

Topic: Chronic Heart Failure

Speaker: Doctor M. Vaduganathan (Boston, US) Assistant Professor J. Ter Maaten (Groningen, NL) Professor K. Marx-Schuett (Aachen, DE) Professor G. Filippatos (Athens, GR)

Sponsored by Bayer AG

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speakers

Doctor Muthiah Vaduganathan

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

39 presentations

15 followers

Assistant Professor Jozine Ter Maaten

University Medical Centre Groningen, Groningen (Netherlands (The))

20 presentations

4 followers

Professor Katharina Marx-Schuett

RWTH University Hospital Aachen, Aachen (Germany)

8 presentations

3 followers

Professor Gerasimos Filippatos

National & Kapodistrian University of Athens Medical School, Athens (Greece)

80 presentations

14 followers

2 more presentations in this session

The evolving treatment landscape in HFmrEF/HFpEF

Speaker: Professor G. Filippatos (Athens, GR)

Close: heart failure care in 2025 and beyond

Speaker: Professor G. Filippatos (Athens, GR)

Access the full session

Improving patient outcomes in heart failure: the role of finerenone

Speakers: Doctor M. Vaduganathan, Assistant Professor J. Ter Maaten, Professor K. Marx-Schuett, Professor G. Filippatos, Professor G. Filippatos...

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

novartis

Explore sponsored resources